Focus on pharmaceutical research and development of core technology

Release: the 2016-08-17 14:54:46

Source: changjiang daily

The reporter Wang Daqian

"This is the best of times, it was the worst of times". In conference room, with formula for graffiti Chen Weijiang sigh for the cause, "because in this era of all innovation, best medicine research and development of the threshold of high technology industry, let a professional standing at the tuyere of the pig all blow up; the worst is because of a need and precipitation industry, impetuous and aggressive is the biggest risk."

Recently, the changjiang daily joint of hubei province listed do open up the new three board of its line of enterprise value to find "the news column, walked into the headquarters in wuhan optical valley biopolis first way pharmaceutical technology co., LTD. (stock code: 832676), the chairman Dr Chen Weijiang told the ft the first road of the development of medicine.

Quit the "iron rice bowl" is professional managers

In 1992, Chen Weijiang graduated from huazhong university of science and pharmacy specialty, then enter the inspection institute of hubei province food and drug research, start from the researcher in biochemical drugs room to do 12 years.

And work very hard at that time, focusing on research and analysis, and I really like about research and development process, and my teacher said I have a talent in this area." Mention entry of this decade, Chen Weijiang filled with nostalgia, and inspection in hubei province food and drug research institute he did biochemical drugs room, deputy director, deputy director of the pharmacists. But this job can't be creative opportunities, not willingly Chen Weijiang did something change destiny: as the "iron rice bowl", to work in private companies.

"Then go to wuhan, a drug firms, relatively fast development, mainly is to help a friend, also consider the private enterprise mechanism is more flexible, my boss and I also have a common professional ideal." Chen Weijiang tells a reporter, in the company, he is responsible for planning the company research and development of strategic development direction, and to conduct a comprehensive research and development management, also at the same time to undertake the construction and development of Shanghai r&d center.

R&d center in Shanghai zhangjiang hi-tech park, Chen Weijiang team began as a child, gradually completed the hardware to the technology of the laboratory management software, from the technical team to the operation of the project the comprehensive construction, laid a solid foundation for the company's technical reserves.

7 years in Shanghai, the company from a small pharmaceutical company, grow up to be in reserve for new drug research and development of large pharmaceutical companies. Chen Weijiang also by the initial project developers, grow into medicine project management and operation experts, he told how to manage the enterprise, how to manage the project have more ideas, he hopes to have more opportunities to practice their career dream, then in early 2011, Chen Weijiang resigned back to the han, considering hubei business in my hometown.

Founded pharmaceutical enterprise stand on the core technology brands

Wuhan in 2011, the pharmaceutical industry vigorous development. "I want to find and I have the same values of industry incubator", Chen Weijiang said, after inspected the wuhan more entrepreneurial base, he selected according to the German standards of laboratory construction of south lake NOVO incubator.

"Leaving wuhan for many years, come back only to find that, wuhan pharmaceutical industry climate has begun to take shape." Chen Weijiang told reporters that choice back to the wuhan business is inevitable. Wuhan has not only the geographical advantages, thorough fares of nine provinces and colleges and universities, is the world the city has the most college students, and, more importantly, start-up costs relative to Beijing, Shanghai, guangzhou, shenzhen and other cities is much lower, is also a livable city. More to the point, "I have accumulated so long, for the pharmaceutical industry has own comprehension, especially drug copy is a combination of the road, has been out of the doorway."

In NOVO incubator between two small lab, Chen Weijiang and two colleagues from Shanghai back together, a total of eight employees began the entrepreneurial journey. Because of the skill, he recognized by customers from the start. A drug firms in wuhan, gave 600000 yuan in cash and two devices; A provincial drug firms to pay more than 100 ten thousand yuan advance payment. With the core technology, the two orders to complete customer satisfaction, first road medical account with this nearly 2 million yuan in cash, also let the start-up Chen Weijiang with confidence.

"When it is pain and happy." Chen Weijiang said, lack of brand, only with the resources to fight for the right employees, lack of money, but the lab with the lowest cost to do in perfect order. Relying on excellent technology, in just two years to complete the declaration of five projects, a number of invention patent application and the national sme innovation fund support.

At this time, and a life changing opportunity arises: a Shanghai has been paying attention to the investment of road first pharmaceutical company decided to participate in the company's business.

Capital drive power "road" first high-speed development

Capital, equity investment,... At that time as a technical expert Chen Weijiang is a stranger to the capital market. Soon after he founded road first medicine, industry information spread in June 2012, after the Shanghai latent Long Hanfeng equity investment fund (hereinafter referred to as the "hidden dragon fund") completion of due diligence, formally in road medicine first.

After professional managers, entrepreneurs and a series of experiences, Chen Weijiang summarizes Chinese medicine research and development enterprise to "walking on two legs", to provide customers with technical services, to obtain cash flow; Reserve for the enterprise characteristic projects, the implementation for the future development. The concept and the hidden dragon fund investment ideas, eventually the other investment of 5 million yuan.

Company account with so much cash at a draught, Chen Weijiang didn't feel happy, instead of pressure. "The money will use the blade, which is responsible for yourself, is also responsible for investors." With the help of the money, the first road medicine completed laboratory scale expanding and has its own project reserves increase. Chen Weijiang told reporters that the introduction of capital, is the power of hope with the help of capital medical member let road had more chances to improve technical strength, the team and project grind the more perfect.

Make Chen Weijiang headache is, however, the standardization of the hidden dragon fund puts forward the relatively strict requirements: company to hire accounting firms, law firms and auditors, strict corporate governance structure and financial system, and to make the company the semi-annual report and annual report. "At that time we really don't understand of these requirements." Chairman secretary lino recalls: "at that time, don't know, why ask companies spend so much cost has nothing to do with technology to do that thing."

A year later, hidden dragon fund to ask for additional investments, then the optical valley biopolis are in development, has formed the pharmaceutical industry and policy of depressions, this time, Chen Weijiang reflection, accepted again hidden dragon fund investment of 5 million yuan. He used the money to buy and lease the optical valley medical park research building, according to the latest standards built the medicine research and development laboratories and production base. It, for the first road medicine is a "metamorphosis".

Listed on the new three board Create independent pharmaceutical products

Early in 2015 to start the new three board plan, only half a year, until June 26, when the first medicine is done on road. Chen Weijiang said that thanks to the early stage of the fund shareholders strict requirements, listed on the work of the new three board makes are doing very well.

In retrospect, then put forward strict requirements, hidden dragon fund is actually accelerating the first road to the development of medicine. Chen Weijiang told reporters: "thanks to the hidden dragon investment, member let road medicine specification management right from the start, has a perfect corporate governance structure, laid a good foundation for subsequent login capital market."

To study medicine after landing new three board, in the first consider raising capital of RMB 20 million for the first time, successfully introduced a medicine marketing channels of shareholders, at the same time the introduction of indigenous medicine "predators" - f medicine as a shareholder. Chen Weijiang says, to raise money for the company to further improve technical strength, the introduction of the two shareholders also for own products company in the future market of the amplification effect.

The power of capital, member let road medicine. The reporter understands, the first road medicine has to reserve a batch of independent research and development projects, including the global approed first P2Y2 receptor agonist eye drops - on the kua phosphorus eye ophthalmic, pediatric preparation and a series of products such as eye drops.

Chen Weijiang also tells a reporter, actively encourage innovation, encourage maximize technology advantage, under the trend of road first ushered in the rapid development of medicine. Especially the liberalization of national policy, "the drug marketing authorisation holder system pilot scheme", let the separation of drug marketing authorisation and production license management mode. Listed under this mechanism, drug license and production license are independent of each other, the marketing authorisation holder can entrust products of different manufacturers, drug safety, efficacy and quality control are listed by licensor shall be responsible for the public. This also member let medical way to focus on technology research and development, become a master the core technology of pharmaceutical research and development enterprise.

Chen Weijiang said, the first road medicine has been committed to the layout with independent intellectual property rights of pharmaceutical products, to prepare for the explosive growth in the future the company performance. At the same time, the company prepared to seek some accord with the development of the industry chain enterprises, at the right time to carry on the merger, acquisition and reorganization, member let road medicine more complete industry chain, truly realize leap-forward development.

The reporter's note > > >

Adhere to the ideal Don't forget the beginner's mind

Choice in his hometown of hubei, is both ideal and realistic choice, business process, the bitter bitterness hone the will of the Chen Weijiang, strengthened the pace of their healthy development.

In fact, in this five years of firm growth, there are all sorts of temptation has been appeared. In those early days, an investment agency has offered ten million yuan of money, want to gain control of the actual road first medicine, but Chen Weijiang refused. "Technology and research and development ability, to believe in yourself more believe that the future of the road first medicine." Chen Weijiang have the feelings of idealism, let he eventually chose "one's own fate grasp".

After landing in new three board, greater temptation comes, an investment institutions to road pharmaceutical holdings at $price first. Chen Weijiang still chose to refuse.

"To be honest, I'm a little idealism feelings, want the first road medicine cutting into the enterprise value in my heart." Chen Weijiang confessed, "I hope I'm good at supremely well."